当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析

永顺生物

(920729)

  

流通市值:7.04亿  总市值:25.04亿
流通股本:7682.50万   总股本:2.73亿

永顺生物(920729)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.30亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益66274.61万元,未分配利润11883.58万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产79105.56万元,负债12830.94万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入179,973,670.63121,726,217.0165,456,650.96268,985,086.87
营业总成本156,149,380.07105,146,428.2858,827,999.72233,726,259.2
其他经营收益
营业利润34,057,129.5821,973,532.748,718,430.1244,184,044.07
利润总额33,998,945.3321,932,915.028,711,054.0644,507,963.72
净利润30,283,823.2719,720,898.197,916,030.8240,143,422.44
每股收益
其他综合收益----
综合收益总额30,283,823.2719,720,898.197,916,030.8240,143,422.44
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计612,154,369.03580,319,845.74601,207,705.58564,818,676.77
非流动资产:
非流动资产合计178,901,183.26183,065,303.42187,802,993.87195,610,979.65
资产总计791,055,552.29763,385,149.16789,010,699.45760,429,656.42
流动负债:
流动负债合计120,625,556.4105,310,687.34109,176,068.8390,109,813.96
非流动负债:
非流动负债合计7,683,849.588,447,891.199,083,350.759,690,609.54
负债合计128,309,405.98113,758,578.53118,259,419.5899,800,423.5
所有者权益(或股东权益):
归属于母公司股东权益合计662,746,146.31649,626,570.63670,751,279.87660,629,232.92
股东权益合计662,746,146.31649,626,570.63670,751,279.87660,629,232.92
负债和股东权益合计791,055,552.29763,385,149.16789,010,699.45760,429,656.42
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计203,404,467.92131,062,431.3863,399,329.16274,807,406.03
经营活动现金流出小计128,742,828.9487,711,875.4146,336,875.46202,270,764.07
经营活动产生的现金流量净额74,661,638.9843,350,555.9717,062,453.772,536,641.96
投资活动产生的现金流量:
投资活动现金流入小计311,473,424.09227,812,633.19120,362,370.26346,420,391.85
投资活动现金流出小计384,789,205.9274,582,659.9167,040,357.9497,050,790.38
投资活动产生的现金流量净额-73,315,781.81-46,770,026.71-46,677,987.64-150,630,398.53
筹资活动产生的现金流量:
筹资活动现金流入小计15,514,413.6215,514,413.6215,514,413.6228,893,932.2
筹资活动现金流出小计36,009,534.8635,854,706.28154,603.1475,456,982.2
筹资活动产生的现金流量净额-20,495,121.24-20,340,292.6615,359,810.48-46,563,050
汇率变动对现金及现金等价物的影响31,809.41104,841.04133,736.22-44,808.91
现金及现金等价物净增加额-19,117,454.66-23,654,922.36-14,121,987.24-124,701,615.48
期末现金及现金等价物余额17,323,119.5212,785,651.8222,318,586.9436,440,574.18
补充资料:
现金及现金等价物的净增加额--23,654,922.36--124,701,615.48
TOP↑